Wordt geladen...
Everolimus in patients with severe pulmonary hypertension: a safety and efficacy pilot trial
Abstract. Despite the availability of vasodilating compounds, pulmonary hypertension (PH) of various origins remains a disease with a poor prognosis. In recent years, pulmonary arterial hypertension (PAH) has been recognized as a predominantly proliferative process. Everolimus, an inhibitor of the m...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
University of Chicago Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4070806/ https://ncbi.nlm.nih.gov/pubmed/24618547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/674311 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|